Use of nuclear magnetic resonance spectroscopy to assess renal dysfunction after hypertonic-hyperoncotic resuscitation in rats

Journal of Trauma - Injury, Infection and Critical Care

Volumn 63, Issue 2, 2007, Pages 379-387

  Amathieu, Roland ^a,b   Racine, Stéphane ^a   Triba, Mohamed ^a   Poloujadoff, Marie Pierre ^a   Borron, Stephen W ^c   Bouchemal, Nadia ^b   Lapostolle, Frédéric ^a   Merouani, Mehdi ^a,b   Le Moyec, Laurence ^a   Adnet, Frédéric ^a,d  

^a UNIVERSITÉ PARIS 13   (France)

^b CHU PURPAN   (France)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d AVICENNE HOSPITAL   (France)

Author keywords

Fluid therapy; Hemorrhage; Magnetic resonance spectroscopy; Nephrotoxicity; Shock

Indexed keywords

ALLANTOIN; CREATININE; HETASTARCH; HETASTARCH 80; HYPERTONIC SOLUTION; NITROGEN; SODIUM CHLORIDE; UNCLASSIFIED DRUG; UREA;

AMPUTATION; ANIMAL MODEL; ARTICLE; BLEEDING; BLOOD PRESSURE; COMPARATIVE STUDY; DRUG INFUSION; EVALUATION; HEMORRHAGIC SHOCK; INFUSION RATE; KIDNEY DYSFUNCTION; MALE; MEAN ARTERIAL PRESSURE; METABOLITE; NEPHROTOXICITY; NITROGEN METABOLISM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; RAT; RESUSCITATION; SURVIVAL; TAIL; URINALYSIS;

ANIMALS; DISEASE MODELS, ANIMAL; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, ACUTE; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, WISTAR; REFERENCE VALUES; RESUSCITATION; RISK ASSESSMENT; SALINE SOLUTION, HYPERTONIC; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SHOCK, HEMORRHAGIC; SURVIVAL RATE;

EID: 34547899620     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/01.ta.0000240459.95717.c0     Document Type: Article

References (40)

1. Soreide E, Deakin CD. Pre-hospital fluid therapy in the critically injured patient - a clinical update. Injury. 2005;36:1001-1010.
2. Dutton RP, Mackenzie CF, Scalea TM. Hypotensive resuscitation during active hemorrhage: impact on in-hospital mortality. J Trauma. 2002;52:1141-1146.
3. Mapstone J, Roberts I, Evans P. Fluid resuscitation strategies: a systematic review of animal trials. J Trauma. 2003;55:571-589.
4. Abu-Hatoum O, Bashenko Y, Hirsh M, Krausz MM. Continuous fluid resuscitation and splenectomy for treatment of uncontrolled hemorrhagic shock after massive splenic injury. J Trauma. 2002;52:253-258.
5. Kreimeier U, Messmer K. Small-volume resuscitation: from experimental evidence to clinical routine. Advantages and disadvantages of hypertonic solutions. Acta Anaesthesiol Scand. 2002;46:625-638.
6. Wade CE, Grady JJ, Kramer GC. Efficacy of hypertonic saline dextran fluid resuscitation for patients with hypotension from penetrating trauma. J Trauma. 2003;54:S144-S148.
7. Younes RN, Aun F, Ching CT, et al. Prognostic factors to predict outcome following the administration of hypertonic/hyperoncotic solution in hypovolemic patients. Shock. 1997;7:79-83.
8. Bunn F, Roberts I, Tasker R, Akpa E. Hypertonic versus isotonic crystalloid for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev. 2002;1:CD002045.
9. Bickell WH, Bruttig SP, Millnamow GA, O'Benar J, Wade CE. Use of hypertonic saline/dextran versus lactated Ringer's solution as a resuscitation fluid after uncontrolled aortic hemorrhage in anesthetized swine. Ann Emerg Med. 1992;21:1077-1085.
10. Gross D, Landau EH, Assalia A, Krausz MM. Is hypertonic saline resuscitation safe in 'uncontrolled' hemorrhagic shock? J Trauma. 1988;28:751-756.
11. Bruscagin V, de Figueiredo LF, Rasslan S, et al. Fluid resuscitation improves hemodynamics without increased bleeding in a model of uncontrolled hemorrhage induced by an iliac artery tear in dogs. J Trauma. 2002;52:1147-1152.
12. Burris D, Rhee P, Kaufmann C, et al. Controlled resuscitation for uncontrolled hemorrhagic shock. J Trauma. 1999;46:216-223.
13. Doucet JJ, Hall RI. Limited resuscitation with hypertonic saline, hypertonic sodium acetate, and lactated Ringer's solutions in a model of uncontrolled hemorrhage from a vascular injury. J Trauma. 1999;47:956-963.
14. Kentner R, Safar P, Prueckner S, et al. Titrated hypertonic/hyperoncotic solution for hypotensive fluid resuscitation during uncontrolled hemorrhagic shock in rats. Resuscitation. 2005;65:87-95.
15. Gurfinkel V, Poggetti RS, Fontes B, da Costa Ferreira Novo F, Birolini D. Hypertonic saline improves tissue oxygenation and reduces systemic and pulmonary inflammatory response caused by hemorrhagic shock. J Trauma. 2003;54:1137-1145.
16. Kreimeier U, Bruckner UB, Niemczyk S, Messmer K. Hyperosmotic saline dextran for resuscitation from traumatic-hemorrhagic hypotension: effect on regional blood flow. Circ Shock. 1990;32:83-99.
17. Capone AC, Safar P, Stezoski SW, Peitzman AB, Tisherman S. Uncontrolled hemorrhagic shock outcome model in rats. Resuscitation. 1995;29:143-152.
18. Capone AC, Safar P, Stezoski W, Tisherman S, Peitzman AB. Improved outcome with fluid restriction in treatment of uncontrolled hemorrhagic shock. J Am Coll Surg. 1995;180:49-56.
19. Soucy DM, Sindlinger JF, Greene SP, et al. Effects of anesthesia on a model of uncontrolled hemorrhage in rats. Crit Care Med. 1995;23:1528-1532.
20. Sondeen JL, Coppes VG, Holcomb JB. Blood pressure at which rebleeding occurs after resuscitation in swine with aortic injury. J Trauma. 2003;54:S110-S117.
21. Riddez L, Johnson L, Hahn RG. Central and regional hemodynamics during crystalloid fluid therapy after uncontrolled intra-abdominal bleeding. J Trauma. 1998;44:433-439.
22. Velasco IT, Pontieri V, Rocha e Silva M Jr, Lopes OU. Hyperosmotic NaCl and severe hemorrhagic shock. Am J Physiol. 1980;239:H664-H673.
23. Velasco IT, Rocha e Silva M, Oliveira MA, Oliveira MA, Silva RI. Hypertonic and hyperoncotic resuscitation from severe hemorrhagic shock in dogs: a comparative study. Crit Care Med. 1989;17:261-264.
24. Richardson D, Deakin CD. Hypertonic saline dextran: a review of current literature. Scand J Trauma Resusc Emerg Med. 2004;12:1-4.
25. Wade CE, Kramer GC, Grady JJ, Fabian TC, Younes RN. Efficacy of hypertonic 7.5% saline and 6% dextran-70 in treating trauma: a meta-analysis of controlled clinical studies. Surgery. 1997;122:609-616.
26. Battison C, Andrews PJ, Graham C, Petty T. Randomized, controlled trial on the effect of a 20% mannitol solution and a 7.5% saline/6% dextran solution on increased intracranial pressure after brain injury. Crit Care Med. 2005;33:196-202.
27. Knapp JM. Hyperosmolar therapy in the treatment of severe head injury in children. AACN Clin Issues. 2005;16:199-211.
28. Fuller TF, Serkova N, Niemann CU, Freise CE. Influence of donor pretreatment with N-acetylcysteine on ischemia/reperfusion injury in rat kidney grafts. J Urol. 2004;171:1296-1300.
29. Le Moyec L, Pruna A, Engene M, et al. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron. 1993;65:433-439.
30. Le Moyec L, Racine S, Le Toumelin P, et al. Aminoglycoside and glycopeptide renal toxicity in intensive care patients studied by proton magnetic resonance spectroscopy of urine. Crit Care Med. 2002;30:1242-1245.
31. Serkova N, Fuller TF, Klawitter J, Freise CE, Niemann CU. H-NMR-based metabolic signatures of mild and severe ischemia/reperfusion injury in rat kidney transplants. Kidney Int. 2005;67:1142-1151.
32. Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmotic-nephrosis-like lesions in kidney transplantation. Lancet. 1993;342:248-249.
33. Bernard C, Alain M, Simone C, Xavier M, Jean-Françcois M. Hydroxyethylstarch and osmotic nephrosis-like lesions in kidney transplants. Lancet. 1996;348:1595.
34. Perazella MA. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am J Med Sci. 2003;325:349-362.
35. Schortgen F, Lacherade JC, Bruneel F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet. 2001;357:911-916.
36. Williams RE, Lenz EM, Evans JA, et al. A combined (1)H NMR and HPLC-MS-based metabonomic study of urine from obese (fa/fa) Zucker and normal Wistar-derived rats. J Pharm Biomed Anal. 2005;38:465-471.
37. Racine SX, Le Toumelin P, Adnet F, et al. N-acetyl functions and acetate detected by nuclear magnetic resonance spectroscopy of urine to detect renal dysfunction following aminoglycoside and/or glycopeptide antibiotic therapy. Nephron Physiol. 2004;97:53-57.
38. Antti H, Bollard ME, Ebbels TM, et al. Batch statistical processing of 1H-NMR derived urinary spectral data. J Chemometrics. 2002;16:461-468.
39. Keun HC, Ebbels TM, Antti H, et al. Analytical reproducibility in (1)H NMR-based metabonomic urinalysis. Chem Res Toxicol. 2002;15:1380-1386.
40. Feng J, Li X, Pei F, et al. 1H NMR analysis for metabolites in serum and urine from rats administrated chronically with La(NO3)3. Anal Biochem. 2002;301:1-7.